Lemborexant Impurity 13 NEW

Lemborexant Impurity 13;2541020-22-6

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

• Product Number: L072013
  English Name: Lemborexant Impurity 13
  English Alias: (1S,2R)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-1-(3-fluorophenyl)cyclopropanecarboxylic acid
  CAS Number: 2541020-22-6
  Molecular Formula: C17H17FN2O3
  Molecular Weight: 316.33
• 
  
• Product Advantages: Lemborexant Impurity 13 has excellent purity and good stability. Its chemical properties are uniform and can remain stable under different experimental conditions. It can be used as a reliable reference substance for pharmaceutical impurity research. Its precise structure and stable properties can effectively improve the accuracy and repeatability of impurity detection, providing a solid basis for pharmaceutical quality control.
  Application Fields: It is mainly applied to the quality control and research and development of Lemborexant drugs. As an impurity reference standard, it is used to develop and validate the detection methods of Lemborexant impurities, ensuring the sensitivity and accuracy of detection methods. In the drug production process, by monitoring the content of this impurity, it helps to optimize the production process and prevent excessive impurities from affecting drug quality. In the study of drug stability, it analyzes its change rules during storage, providing key references for determining the shelf life and suitable storage conditions of drugs.
  Background Description: Lemborexant is used to treat insomnia, and its drug quality is related to the safety and treatment effect of patients' medication. Impurities in drugs may affect drug activity, stability and safety. Impurity research is the core content of drug research and development, production and quality control. As a related impurity of Lemborexant, the research on the characteristics and content of Lemborexant Impurity 13 helps to comprehensively evaluate the quality of Lemborexant drugs and ensure the safety and effectiveness of clinical medication.
  Research Status: Currently, research on Lemborexant Impurity 13 continues to deepen. In terms of detection technology, advanced methods such as high - resolution mass spectrometry - chromatography are constantly being explored to achieve accurate detection of trace impurities. In terms of impurity generation mechanisms, the formation causes and influencing factors are deeply analyzed by simulating drug synthesis and storage environments, providing theoretical support for controlling impurities from the source. At the same time, research on the impact of this impurity on the safety and effectiveness of Lemborexant drugs has also been gradually carried out, aiming to improve the comprehensive understanding of the quality of Lemborexant drugs.

NOTE！

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!